0

Journal Articles

in Vascular Surgery
 1-20 of 68 Articles
Perspectives |  October 22, 2012 FREE
An Unmeasured Harm of Screening
Vinay Prasad, MD
Arch Intern Med. 2012;172(19):1442-1443. doi:10.1001/2013.jamainternmed.682.
Perspectives |  August 13, 2012 FREE
“My Mother Was 67 . . . ”
Eric B. Larson, MD, MPH; Janice King
Arch Intern Med. 2012;172(15):1132. doi:10.1001/archinternmed.2012.2568.
Invited Commentary |  August 13, 2012
How Drug-Eluting Stents Illustrate Our Health System's Flawed Relationship With Technology:  Comment on “Use of Drug-Eluting Stents as a Function of Predicted Benefit”
Peter W. Groeneveld, MD, MS
Arch Intern Med. 2012;172(15):1152-1153. doi:10.1001/archinternmed.2012.2724.
Original Investigation |  August 13, 2012
Use of Drug-Eluting Stents as a Function of Predicted Benefit:  Clinical and Economic Implications of Current Practice
Amit P. Amin, MD, MSc; John A. Spertus, MD, MPH; David J. Cohen, MD, MSc; et al.
Arch Intern Med. 2012;172(15):1145-1152. doi:10.1001/archinternmed.2012.3093.
INCLUDES: , Supplemental Content
Editor's Correspondence |  July 09, 2012
Percutaneous Coronary Intervention for Stable Coronary Artery Disease: The Debate Continues
Elvis A. Peter, MD; Nuri I. Akkus, MD; Jai Varma, MD, FSCAI
Arch Intern Med. 2012;172(13):1043-1044. doi:10.1001/archinternmed.2012.1753.
Invited Commentary |  June 11, 2012
Routine Periodic Stress Testing in Asymptomatic Patients Following Coronary Revascularization: Is It Worth the Effort?:  Comment on “Exercise Testing in Asymptomatic Patients After Revascularization”
Mark J. Eisenberg, MD, MPH
Arch Intern Med. 2012;172(11):861-863. doi:10.1001/archinternmed.2012.1910.
Original Investigation |  June 11, 2012
Exercise Testing in Asymptomatic Patients After Revascularization:  Are Outcomes Altered?
Serge C. Harb, MD; Thomas Cook, MPH, PhD; Wael A. Jaber, MD; et al.
Arch Intern Med. 2012;172(11):854-861. doi:10.1001/archinternmed.2012.1355.
Invited Commentary |  June 11, 2012
Activating Primary Percutaneous Coronary Intervention for STEMI That Is Not: The Collateral Damage of Improving Door-to-Balloon Time:  Comment on “Prevalence and Factors Associated With False-Positive ST-Segment Elevation Myocardial Infarction Diagnoses at Primary Percutaneous Coronary Intervention–Capable Centers”
Fouad Bachour, MD; Richard Asinger, MD
Arch Intern Med. 2012;172(11):871. doi:10.1001/archinternmed.2012.1117.
Original Investigation |  June 11, 2012
Prevalence and Factors Associated With False-Positive ST-Segment Elevation Myocardial Infarction Diagnoses at Primary Percutaneous Coronary Intervention–Capable Centers:  A Report From the Activate-SF Registry
James M. McCabe, MD; Ehrin J. Armstrong, MD, MSc; Ameya Kulkarni, MD; et al.
Arch Intern Med. 2012;172(11):864-871. doi:10.1001/archinternmed.2012.945.
Invited Commentary |  April 23, 2012
Drug-Eluting Stents in ST-Segment Elevation Myocardial Infarction:  Comment on “Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty”
James M. Brophy, MEng, MD, PhD
Arch Intern Med. 2012;172(8):621-622. doi:10.1001/archinternmed.2012.694.
Review Article |  April 23, 2012 FREE
Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty:  A Pooled Patient-Level Meta-analysis of Randomized Trials
Giuseppe De Luca, MD, PhD; Maurits T. Dirksen, MD; Christian Spaulding, MD; et al.
Arch Intern Med. 2012;172(8):611-621. doi:10.1001/archinternmed.2012.758.
Invited Commentary |  March 26, 2012
Interpreting Biomarkers During Percutaneous Coronary Intervention: The Need to Reevaluate Our Approach:  Comment on “Troponin Criteria for Myocardial Infarction After Percutaneous Coronary Intervention”
Joseph S. Alpert, MD; Allan S. Jaffe, MD
Arch Intern Med. 2012;172(6):508-509. doi:10.1001/archinternmed.2011.2284.
Invited Commentary |  February 27, 2012
Mounting Evidence for Lack of PCI Benefit in Stable Ischemic Heart Disease:What More Will It Take to Turn the Tide of Treatment?:  Comment on "Initial Coronary Stent Implantation With Medical Therapy vs Medical Therapy Alone for Stable Coronary Artery Disease"
William E. Boden, MD
Arch Intern Med. 2012;172(4):319-321. doi:10.1001/archinternmed.2011.2321.
Original Investigation |  February 27, 2012 FREE
A Randomized Controlled Trial of Positive-Affect Induction to Promote Physical Activity After Percutaneous Coronary Intervention
Janey C. Peterson, EdD, MS, RN; Mary E. Charlson, MD; Zachary Hoffman, BS; et al.
Arch Intern Med. 2012;172(4):329-336. doi:10.1001/archinternmed.2011.1311.
Editorial |  January 23, 2012
Reconsidering Transfer for Percutaneous Coronary Intervention Strategy:  Time Is of the Essence
Rita F. Redberg, MD, MSc
Arch Intern Med. 2012;172(2):98-99. doi:10.1001/archinternmed.2011.566.
Invited Commentary |  January 23, 2012
Prediction Is Very Hard, Especially About the Future:  Comment on “Factors Associated With 30-Day Readmission Rates After Percutaneous Coronary Intervention”
Adrian F. Hernandez, MD, MHS; Christopher B. Granger, MD
Arch Intern Med. 2012;172(2):117-119. doi:10.1001/archinternmed.2011.568.
Research Letters |  January 23, 2012 FREE
Improvement in Revascularization Time After Creation of a Coronary Catheterization Laboratory at a Public Hospital
Eric A. Secemsky, MD; David Lange, MD; Jennifer E. Ho, MD; et al.
Arch Intern Med. 2012;172(2):193-194. doi:10.1001/archinternmed.2011.564.
Original Investigation |  January 23, 2012 FREE
Factors Associated With 30-Day Readmission Rates After Percutaneous Coronary Intervention
Farhan J. Khawaja, MD; Nilay D. Shah, PhD; Ryan J. Lennon, MS; et al.
Arch Intern Med. 2012;172(2):112-117. doi:10.1001/archinternmed.2011.569.
Research Letters |  November 28, 2011 FREE
Prognostic Impact of Hospital Readmissions After Primary Percutaneous Coronary Intervention
Gianluca Campo, MD; Francesco Saia, MD, PhD; Paolo Guastaroba, MSc; et al.
Arch Intern Med. 2011;171(21):1948-1949. doi:10.1001/archinternmed.2011.536.
Editor's Correspondence |  November 28, 2011
Percutaneous Coronary Intervention for Persistent Occlusion of the Infarct-Related Artery: An Expanded View of the Evidence—Reply
Judith S. Hochman, MD; Christopher E. Buller, MD
Arch Intern Med. 2011;171(21):1962-1963. doi:10.1001/archinternmed.2011.552.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Dermatology
Observation  |  April 01, 2013
Cutaneous Epithelioid Sarcomalike (Pseudomyogenic) Hemangioendothelioma:  A Little-Known Low-Grade Cutaneous Vascular Neoplasm
Luis Requena, MD; Carlos Santonja, MD; Jose Luis Martinez-Amo, MD; et al.
JAMA Surgery
Original Article  |  December 17, 2012
Concomitant Vascular Reconstruction During Pancreatectomy for Malignant Disease:  A Propensity Score–Adjusted, Population-Based Trend Analysis Involving 10 206 Patients
Mathias Worni, MD; Anthony W. Castleberry, MD; Bryan M. Clary, MD; et al.
JAMA Surgery
Invited Critique  |  December 17, 2012
Show Us the Money:  Comment on “Concomitant Vascular Reconstruction During Pancreatectomy for Malignant Disease”
E. Christopher Ellison, MD
JAMA
JAMA Patient Page  |  March 27, 2013
Treatment of Varicose Veins
Allen Hamdan, MD; Edward H. Livingston, MD; Cassio Lynm, MA
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems